Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 21

Trial Status

Completed4

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT02232152Phase 1Completed
CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+13 more
PrincipalinvestigatorStart date: 2015-01-06
NCT01835041Phase 1Completed
CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
PrincipalinvestigatorStart date: 2013-04-01
NCT01766219Phase 1/2Completed
CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery
Adult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+6 more
Principalinvestigator
NCT01839981Phase 1Completed
CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hedy Kindler

University of Chicago Comprehensive Cancer Center

Related
6 trials

Shared therapeutic areas:

Stage III Pancreatic CancerStage IV Pancreatic CancerRecurrent Pancreatic Cancer+23 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score26%

Wen Wee Ma

Roswell Park Cancer Institute

Related
5 trials

Shared therapeutic areas:

Stage IV Pancreatic CancerDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+12 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Betty Ferrell

City of Hope Medical Center

Related
5 trials

Shared therapeutic areas:

Recurrent Colon CancerRecurrent Pancreatic CancerRecurrent Rectal Cancer+12 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Hedy Kindler

University of Chicago

Related
5 trials

Shared therapeutic areas:

Adult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+10 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

Crystal Denlinger, MD

Fox Chase Cancer Center

Related
3 trials

Shared therapeutic areas:

Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Colon+7 more
Similarity Score10%

Stephen Michael Hahn

Abramson Cancer Center at Penn Medicine

Related
6 trials

Shared therapeutic areas:

Advanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver CancerRecurrent Adult Primary Liver Cancer+7 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Joshua Meyer

Fox Chase Cancer Center

Related
3 trials

Shared therapeutic areas:

Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasMucinous Adenocarcinoma of the Rectum+6 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Virginia Sun

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Stage III Pancreatic CancerStage IV Pancreatic CancerRecurrent Pancreatic Cancer+6 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Tanios Bekaii-Saab

Ohio State University

Related
3 trials

Shared therapeutic areas:

Recurrent Extrahepatic Bile Duct CancerUnresectable Extrahepatic Bile Duct CancerAdult Primary Cholangiocellular Carcinoma+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Sanjiv Gambhir, MD, PhD

Stanford University

Related
3 trials

Shared therapeutic areas:

Recurrent Colon CancerRecurrent Pancreatic CancerRecurrent Rectal Cancer+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02232152Phase 1PrincipalInvestigator

CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+13 more
Completed
NCT01835041Phase 1PrincipalInvestigator

CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer

Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
Completed
NCT01766219Phase 1/2PrincipalInvestigator

CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery

Adult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+6 more
Completed
NCT01839981Phase 1PrincipalInvestigator

CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
Completed

All 4 trials loaded